Regulus Therapeutics (RGLS) Stock Chart & Stock Price History $8.16 0.00 (0.00%) As of 06/25/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Regulus Therapeutics Stock Price Performance The Regulus Therapeutics (RGLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 329.47%, with a year-to-date return of 416.46%. In the past month, the stock has increased 2.90%, reflecting recent market activity. As of the latest close, Regulus Therapeutics traded at $8.16 with a market cap of $564.92 million and volume of 0 shares. Five years ago, the stock traded at a split-adjusted price of $6.82, representing a 19.74% increase over that period. At the time, it had a market cap of $15.04 million and a volume of 1.37 million shares. Receive RGLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance+2.90%3 Month Performance+366.29%Year-To-Date Performance+416.46%1 Year Performance+329.47%5 Year Performance+19.74% RGLS Stock Chart for Tuesday, July, 1, 2025 RGLS Chart by TradingView Regulus Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/25/2025$8.16$8.04-1.53%$8.18$8.079.34 million shs$556.30 million06/24/2025$8.14$8.16+0.25%$8.18$8.079.32 million shs$564.92 million06/23/2025$7.88$8.14+3.30%$8.17$8.055.00 million shs$563.53 million06/20/2025$8.21$7.88-4.02%$8.24$7.7517.02 million shs$545.56 million06/19/2025$8.21$8.21$8.29$8.171.37 million shs$568.38 million06/18/2025$8.20$8.21+0.12%$8.29$8.171.37 million shs$568.38 million06/17/2025$8.22$8.20-0.24%$8.24$8.161.16 million shs$567.72 million06/16/2025$8.11$8.22+1.36%$8.28$8.071.16 million shs$569.10 million06/13/2025$8.08$8.11+0.37%$8.12$8.02970,988 shs$561.49 million06/12/2025$8.15$8.08-0.86%$8.15$8.061.27 million shs$559.41 million Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/11/2025$8.30$8.15-1.81%$8.32$8.15714,583 shs$564.26 million06/10/2025$8.30$8.30$8.31$8.22727,464 shs$574.64 million06/09/2025$8.22$8.30+0.97%$8.35$8.221.48 million shs$574.64 million06/06/2025$8.10$8.22+1.48%$8.28$8.072.78 million shs$569.10 million06/05/2025$7.95$8.10+1.89%$8.13$7.982.36 million shs$560.80 million06/04/2025$7.97$7.95-0.25%$7.99$7.94686,079 shs$550.41 million06/03/2025$7.94$7.97+0.38%$7.99$7.94808,763 shs$551.80 million06/02/2025$7.93$7.94+0.13%$7.98$7.911.30 million shs$549.72 million05/30/2025$7.94$7.93-0.13%$7.95$7.911.00 million shs$549.03 million Related Companies BioCryst Pharmaceuticals Stock Price Chart Amicus Therapeutics Stock Price Chart Celldex Therapeutics Stock Price Chart Innoviva Stock Price Chart Dynavax Technologies Stock Price Chart MannKind Stock Price Chart Novavax Stock Price Chart OPKO Health Stock Price Chart Geron Stock Price Chart Myriad Genetics Stock Price Chart Receive RGLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RGLS) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
